Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of May 2019
Date of Filing: May 1, 2019
This filing serves to incorporate a press release by reference, announcing a corporate action regarding the company's American Depositary Shares (ADSs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notification of a capital structure change and does not contain financial performance data.
Material Changes
- ADS Ratio Change: The company announced a change in the ratio of its American Depositary Shares (ADSs) to ordinary shares.
- Previous Ratio: 1 ADS represented 2 ordinary shares.
- New Ratio: 1 ADS will represent 30 ordinary shares.
- Effective Date: The change is effective as of May 10, 2019.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items beyond the announcement of the ADS ratio adjustment.
Investor Verification Checklist
- Verify the effective date of the ADS ratio change (May 10, 2019).
- Confirm the new conversion ratio (1 ADS = 30 ordinary shares) in subsequent trading data.
- Review the attached press release (Exhibit 99.1) for any additional details on the rationale for the change.
- Check for any impact on the number of outstanding ADSs following the ratio adjustment.